Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class ...

Defiant is a new early stage VC firm focused on B2B SaaS and fintech coming out of stealth Thursday. Joseph Pizzolato ...

UST, a leading digital transformation solutions company, announced its partnership with Keycentrix, a leading provider of pharmacy software and technology solutions, to enhance Keycentrix's product ...